Literature DB >> 11587790

RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production.

O Vieira-da-Motta1, P D Ribeiro, W Dias da Silva, E Medina-Acosta.   

Abstract

Staphylococcal enterotoxins (SEs) are emetic toxins that cause food poisoning. SEs also function as powerful pyrogenic toxin superantigens that stimulate non-specific T-cell proliferation. Together with the hemolysins, SEs have been largely implicated as virulence factors in multiple infection models. Recent biochemical and genetic analyses have demonstrated that production of some of these toxins is partially regulated by quorum sensing mechanisms where proteins and peptides activate the accessory gene regulator (agr). Because toxin production is central to bacterial pathogenesis, therapeutic strategies alternative to antibiotics, and based on rational interference of the quorum sensing systems involved, are currently being developed. This approach would lead to repression of toxin production and, thus, to disease prevention. Here we provide evidence to conclude that synthetic analogs of the RNAIII inhibiting peptide (RIP) and antibodies to its target molecule TRAP function in vitro as efficient suppressors of agr-regulated exotoxin production by Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587790     DOI: 10.1016/s0196-9781(01)00497-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence.

Authors:  Moshe Korem; Yael Gov; Madanahally D Kiran; Naomi Balaban
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

Authors:  Naomi Balaban; Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Joel B Braunstein; Carmela Silvestri; Federico Mocchegiani; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation.

Authors:  Laura H Tsang; Sonja T Daily; Elizabeth C Weiss; Mark S Smeltzer
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

4.  Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing.

Authors:  C A Martin; A D Hoven; A M Cook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-06       Impact factor: 3.267

5.  Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis.

Authors:  Jiro Nakayama; Emi Tanaka; Reiko Kariyama; Koji Nagata; Kenzo Nishiguchi; Ritsuko Mitsuhata; Yumi Uemura; Masaru Tanokura; Hiromi Kumon; Kenji Sonomoto
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

6.  Staphylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cultures.

Authors:  Sergine Even; Cathy Charlier; Sébastien Nouaille; Nouri L Ben Zakour; Marina Cretenet; Fabien J Cousin; Michel Gautier; Muriel Cocaign-Bousquet; Pascal Loubière; Yves Le Loir
Journal:  Appl Environ Microbiol       Date:  2009-05-08       Impact factor: 4.792

7.  RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.

Authors:  Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Maria Simona Del Prete; Federico Mocchegiani; Vittorio Saba; Fiorenza Orlando; Giorgio Scalise; Naomi Balaban; Giorgio Dell'Acqua
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

8.  Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus.

Authors:  Lindsey N Shaw; Ing-Marie Jonsson; Vineet K Singh; Andrej Tarkowski; George C Stewart
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

9.  Growth inhibition of Staphylococcus aureus and escherichia coli strains by neutralizing IgY antibodies from ostrich egg yolk.

Authors:  Fernando Luiz Tobias; Luize Néli Nunes Garcia; Milton Masahiko Kanashiro; Enrique Medina-Acosta; João Gato Brom-de-Luna; Claudia Maria Costa de Almeida; Romildo Rocha Azevedo Junior; Môsar Lemos; Olney Vieira-da-Motta
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Rauvolfia grandiflora (apocynaceae) extract interferes with staphylococcal density, enterotoxin production and antimicrobial activity.

Authors:  Lanamar de Almeida Carlos; Kenas Aguiar da Silva Amaral; Ivo José Curcino Vieira; Leda Mathias; Raimundo Braz-Filho; Solange Silva Samarão; Olney Vieira-da-Motta
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.